Doliver Advisors’s Neuberger High Yield Strategies Fund Inc NHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-53,023
Closed -$581K 195
2018
Q3
$581K Sell
53,023
-6,181
-10% -$67.3K 0.24% 57
2018
Q2
$641K Buy
59,204
+22,895
+63% +$252K 0.27% 57
2018
Q1
$404K Buy
+36,309
New +$413K 0.18% 101
2017
Q3
Sell
-26,322
Closed -$313K 290
2017
Q2
$313K Buy
26,322
+52
+0.2% +$620 0.15% 142
2017
Q1
$312K Buy
26,270
+12,816
+95% +$152K 0.25% 135
2016
Q4
$157K Buy
+13,454
New +$155K 0.13% 193
2015
Q4
Sell
-15,214
Closed -$155K 201
2015
Q3
$155K Sell
15,214
-14,453
-49% -$158K 0.12% 175
2015
Q2
$349K Buy
29,667
+12,064
+69% +$148K 0.23% 141
2015
Q1
$217K Buy
+17,603
New +$219K 0.14% 195
2014
Q4
Sell
-24,522
Closed -$317K 273
2014
Q3
$317K Sell
24,522
-33
-0.1% -$442 0.22% 177
2014
Q2
$340K Buy
+24,555
New +$337K 0.3% 135
2013
Q4
Sell
-24,367
Closed -$318K 313
2013
Q3
$318K Sell
24,367
-19,033
-44% -$245K 0.2% 207
2013
Q2
$556K Buy
+43,400
New +$600K 0.33% 120

Other funds holding NHS

Doliver Advisors's NHS Position: Q4 2018 in Review

Doliver Advisors sold out of Neuberger High Yield Strategies Fund Inc (NHS) in Q4 2018, closing a stake of 53,023 shares — an estimated $581K sold.

Doliver Advisors first reported a position in NHS in Q2 2013 and held it in 13 quarters. The position peaked at $641K in Q2 2018. 49 funds tracked by Wall St. Rank hold NHS as of Q4 2018.

  • Doliver Advisors reported no remaining Neuberger High Yield Strategies Fund Inc position as of Q4 2018 after selling out during the quarter.
  • Doliver Advisors sold 53,023 Neuberger High Yield Strategies Fund Inc shares in Q4 2018, an estimated $581K.
  • Doliver Advisors first reported a position in Neuberger High Yield Strategies Fund Inc in Q2 2013 and held it in 13 quarters.
  • Doliver Advisors's Neuberger High Yield Strategies Fund Inc position peaked at $641K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Neuberger High Yield Strategies Fund Inc as of Q4 2018.

Based on Doliver Advisors's 13F filing for Q4 2018, filed 31 Jan 2019.